From: XXXX XXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXX
Sent: 01 April 2021 13:15
To: Maria Pitan XXXXXXXXXXXXXXXXXXXXXXX
XXXXXXX XXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Cc: David Coombs XXXXXXXXXXXXXXXXXXXXXXXX
Lucinda Evans XXXXXXXXXXXXXXXXXXXXXXXXX
Sandra M. Robinson XXXXXXXXXXXXXXXXXXXXXXXXXXX
Mandy Tonkinson XXXXXXXXXXXXXXXXXXXXXXXXXXX
Heidi Livingstone XXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXX XXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Subject: RE: Initial scrutiny letter mogamulizumab ID1405_Joint LA LC
Dear Maria,
On behalf of
Leukaemia Care and Lymphoma Action I can confirm that we are happy to proceed
with the appeal on the basis proposed by Mr Irish in the initial scrutiny
letter.
We will nominate
representatives to attend the appeal hearing in due course, ahead of the deadline
of the 19th April.
Kind Regards,
XXXX
XXXX XXXXXXXXXXXXXXXXX
XXXXX XXXXXXXXX XXXXXXX
A: One Birch
Court, Blackpole East, Worcester, WR3 8SG
T: 01905 755977
W: www.leukaemiacare.org.uk
To: Help us to help others #SpotLeukaemia in 2021. Visit spotleukaemia.org.uk for more information.
Leukaemia Care is registered as a charity in England and Wales
(no.1183890) and Scotland (no. SCO49802).
Company number: 11911752. Registered office address: One Birch Court,
Blackpole East, Worcester, WR3 8SG
This page was last updated: